Horizon Therapeutics Plc
(NASDAQ : HZNP)

( )
HZNP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.44%30.2414.1%$177.94m
HZNPHorizon Therapeutics Plc -0.19%91.455.5%$174.64m
GWPHGW Pharmaceuticals Plc 0.17%218.366.1%$132.57m
CTLTCatalent, Inc. 0.86%109.982.1%$128.58m
BHCBausch Health Cos., Inc. 1.44%30.240.0%$123.31m
ICLRICON plc -0.81%196.434.2%$121.81m
UTHRUnited Therapeutics Corp. 1.75%202.7814.1%$98.97m
JAZZJazz Pharmaceuticals Plc 1.87%166.372.3%$88.00m
SAVACassava Sciences, Inc. -1.00%35.670.0%$69.79m
ARGXargenx SE 1.41%272.780.0%$50.95m
SAGESAGE Therapeutics, Inc. 5.19%75.677.6%$37.98m
PRGOPerrigo Co. Plc 0.65%40.416.9%$37.14m
AMRNAmarin Corp. Plc 0.59%5.111.5%$28.81m
PCRXPacira Biosciences, Inc. 1.71%69.439.9%$26.96m
ICPTIntercept Pharmaceuticals, Inc. 1.13%21.4116.8%$21.61m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.